Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles. - Wikidata - wikimedia - TriplyDB

Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.

Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.

http://www.wikidata.org/entity/Q34350701

about

Endometriosis: where are we and where are we going?Endometriosis and ovarian cancer: links, risks, and challenges faced An Immunohistochemical Algorithm for Ovarian Carcinoma Typing.The significance of markers in the diagnosis of endometrial cancer New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care Structural mutation analysis of PTEN and its genotype-phenotype correlations in endometriosis and cancer Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer.The promise and challenge of ovarian cancer models.Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report.Arid1a inactivation in an Apc- and Pten-defective mouse ovarian cancer model enhances epithelial differentiation and prolongs survival.Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.Genetic and molecular changes in ovarian cancer.ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas.Understanding Molecular Landscape of Endometrial Cancer through Next Generation Sequencing: What We Have Learned so Far?Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma.Role of Wnt/β-catenin, Wnt/c-Jun N-terminal kinase and Wnt/Ca2+ pathways in cisplatin-induced chemoresistance in ovarian cancer.Ovarian cancer in endometriosis: clinical and molecular aspects.Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer.Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications.The emerging roles of ARID1A in tumor suppression.Novel insights on the malignant transformation of endometriosis into ovarian carcinoma.Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer.Immunohistochemical characterization of endometrial carcinomas: endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis.The role of microRNAs in the pathogenesis of endometrial cancer: a systematic review.Mutational heterogeneity in non-serous ovarian cancers.Progression inference for somatic mutations in cancer.The changing landscape of gynaecological cancer diagnosis: implications for histopathological practice in the 21st century.Prediction of therapy response in ovarian cancer: Where are we now?Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.Effects of Endocrine-Disrupting Chemicals and Epigenetic Modifications in Ovarian Cancer: A Review.Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses.Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse.Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups.Low Arid1a Expression Correlates with Poor Prognosis and Promotes Cell Proliferation and Metastasis in Osteosarcoma.Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers.Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality.Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden.Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.Unraveling endometriosis-associated ovarian carcinomas using integrative proteomics.

P2860

Q26750772-3FCB86EC-ADF6-4DCB-ADD0-4915E6AB414E Q27003273-AB6E59B6-ED20-42EB-9FD6-07F64D20A38B Q27313766-4A51E7F6-F03A-44E7-B90A-812FC279F5FE Q28067066-4C3794C3-3770-45F2-805C-73586392B161 Q28078792-599B118A-8DBE-46D2-AA06-3FD8A7C166CA Q30391301-7B642BD2-B4C0-4B90-82EC-D1155F22DD37 Q33752609-AE17420E-4CCD-4D67-9343-EBB061230A66 Q35691011-CDC0B8DC-EBB5-4E1A-A2FF-A423F7D16A0E Q35771750-9C9314D5-63AB-4F37-89AB-F1D3BEAC0A1D Q36254394-464DD823-E761-481A-B354-182EF4D32E97 Q36469778-84CD50E6-3A4A-488C-8531-A4079BD558C6 Q37007851-134F6C0C-C310-4501-8597-832CB0B58E95 Q37094076-14BC9D83-3515-4B51-B0CC-F374F9995A63 Q37225222-97B12BE5-EDD1-4370-BAF3-43980788E5F4 Q37382351-0703B82A-A725-4C54-9F13-74463A1F1B5B Q37388203-36B7955E-827C-4BED-9795-4634FA8C33F3 Q37582011-91A28BA2-A68E-4A0B-893C-C9244326321C Q37645709-F79065F0-4CAA-4679-B6C1-67AC9613347C Q37723027-AA2C5E94-DB94-4D74-BFA9-A80695A74B4E Q37729055-8E074FEA-39D3-458C-A306-0FD621512415 Q38195175-A0E43F27-6E37-459F-91B4-297D8EB2F786 Q38218228-6CEF59B3-DABF-4A50-9947-2713F7754C4B Q38242086-503D7B0C-DAE0-47C0-A190-C9305EC76A39 Q38264390-3CDAD9E8-56A8-4CF4-8715-6D74014ECBA8 Q38362213-AD1AA896-C423-4C15-992C-47BAB179E9ED Q38602953-E78643C0-F167-4299-A928-6B800CEAC0BC Q38793244-563EE037-F556-4574-8E83-E20113577C29 Q39037647-98CFDF79-0AFC-43DE-A1CF-97621668B26E Q39263260-E11D1768-594A-4C5D-802E-18B98D6A4037 Q39345895-89F34313-031A-44A4-A0FE-2B5846B3E0D3 Q39364797-88C94BE1-8924-4F29-8ACD-1085EB5A9440 Q40290088-67C271B3-766B-48D8-90DA-1C9FEF3E2C51 Q42671513-00C5DFC3-17E2-4D3F-9B1E-79560736B8A2 Q46364204-6E452ABD-987A-4F9D-B9D4-3E401F03A354 Q47362802-4AB9BAEC-67B0-432B-B1C8-B29B5930547B Q50127508-9683610C-C1A6-4DB5-A33D-330DE1504D2F Q52886475-52B07DCB-B52D-480E-8787-958359DEF2EB Q54289649-394FFE28-4C51-42CD-9098-538421F482A2 Q54324522-09A42387-4220-4453-AFC2-E50E92109158 Q55256135-1FDE4C8A-A16A-4FBD-9299-6DDC2442E771

P2860

Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.

http://www.wikidata.org/entity/Q34350701

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.

@ast

Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.

@en

Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.

@nl

type

label

Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.

@ast

Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.

@en

Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.

@nl

prefLabel

Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.

@ast

Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.

@en

Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.

@nl

P1433

Q34350701-555D87C5-C59C-43ED-9D1E-08D9AE44448A

P1476

Q34350701-9C9B07DF-4A67-46D4-9A3B-D3C60AF0FB1D

P2093

Q34350701-03511226-8811-4433-A0AA-809E289CE881

Q34350701-048A5B31-8ADC-4468-93A2-04E89D615398

Q34350701-14A05EFE-7F8B-4D95-BAFC-8E3319CD51F6

Q34350701-1F728E38-762C-430D-907A-5F23B132FD66

Q34350701-25E2A581-19FD-4BF4-8644-45518D3BE895

Q34350701-394ECE48-1472-4D77-8715-C16D7E0A4F8C

Q34350701-72FCFA43-4761-40A5-A0B6-E1085868C0C9

Q34350701-7B9FBB04-E465-4C81-9A4D-75C2A2D7601C

Q34350701-83E42B81-B49A-480A-BB35-310D502B29F1

Q34350701-9DDE79A5-A366-4EE2-9F99-9D8B2EBB0236

P2860

Q34350701-01500FBC-DC1A-4E1B-BACE-E1907DB6AAC9

Q34350701-12DFC2F6-9849-4937-B128-D17811F15EF5

Q34350701-2181DDFE-BB6E-4C02-A4A4-AB147436218F

Q34350701-2FD63E7A-E23C-4639-BEEF-4D2781D3FDA2

Q34350701-32C9F0F2-B40C-4CD8-BE3E-4CDE01895B16

Q34350701-3643801D-97A8-4E77-9EC4-548AB0C98A92

Q34350701-38B8792A-E03A-44DA-9A59-8D37515E07C1

Q34350701-3E16FE1C-08C0-417E-A086-D80EE82C8C9C

Q34350701-41CCF800-C90A-4747-87F6-1420CDBBDC3A

Q34350701-534ADC63-E1B9-4B3D-AAFE-D424C5BE8BDA

P2888

Q34350701-46D314FB-52B7-48BF-8C66-B3F82BB3E906

P304

Q34350701-FF517D77-F179-4B54-88E8-490BCFF48D5A

P31

Q34350701-15C2FE34-A933-4E40-9D7B-3EF380B74E3A

P356

Q34350701-BBC742DB-AF6A-49AA-971A-8843EF0980A5

P433

Q34350701-1E304553-D7DD-4B5A-96F5-48463F54B8C5

P478

Q34350701-9A0B204A-17A1-4FED-BC73-52D1F5B5ED52

P577

Q34350701-DAC66380-E58F-4AC5-8D48-40F4A4498C59

P5875

Q34350701-28CEB82B-885F-473D-AD70-69619F6C0A78

P6179

Q34350701-9B6CEE93-D920-4CC5-AA05-CAF6B2690B59

P698

Q34350701-02E635DC-9C29-4D89-AE0B-C9BC5EB43600

P932

Q34350701-0D268C9C-A705-4B84-B830-65761C6B6E0F

P356

MODPATHOL.2013.107

P1433

Modern Pathology

P1476

Ovarian and endometrial endome ...... B1 and PTEN mutation profiles.

@en

P2093

Alicia A Tone

http://www.w3.org/2001/XMLSchema#string

C Blake Gilks

http://www.w3.org/2001/XMLSchema#string

Cheng-Han Lee

http://www.w3.org/2001/XMLSchema#string

David G Huntsman

http://www.w3.org/2001/XMLSchema#string

Janine Senz

http://www.w3.org/2001/XMLSchema#string

Jessica N McAlpine

http://www.w3.org/2001/XMLSchema#string

Jiarui Ding

http://www.w3.org/2001/XMLSchema#string

Kimberly C Wiegand

http://www.w3.org/2001/XMLSchema#string

Leah M Prentice

http://www.w3.org/2001/XMLSchema#string

Melissa K McConechy

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Association of the APC gene product with beta-catenin

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

Clinical practice. Endometriosis

Fast and accurate short read alignment with Burrows-Wheeler transform

Integrated genomic analyses of ovarian carcinoma

High frequency of mutations of the PIK3CA gene in human cancers

Association of the APC tumor suppressor protein with catenins

FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features

Wnt signalling and its impact on development and cancer

P2888

modpathol.2013.107

P304

128-134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2013.107

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237839859

http://www.w3.org/2001/XMLSchema#string

P6179

1026225969

http://www.w3.org/2001/XMLSchema#string

P698

23765252

http://www.w3.org/2001/XMLSchema#string

P932

3915240

http://www.w3.org/2001/XMLSchema#string